BACKGROUND:Laparoscopic surgery has proven to be safe and effective. However, the value of laparoscopic resection for malignancy in terms of cancer outcome can only be assessed by large prospective randomized clinical trials with sufficient follow-up. METHODS:COLOR (COlon carcinoma Laparoscopic or Open Resection) is a European multicenter randomized trial which has started in September 1997. In 24 hospitals in Sweden, The Netherlands, Germany, France, Italy and Spain, 1,200 patients will be included. The primary end point of the study is cancer-free survival after 3 years. RESULTS: Within <2 years, more than 540 patients have been randomized for right hemicolectomy (45%), left hemicolectomy (10%) and sigmoidectomy (45%). 33 patients (6%) were excluded after randomization. The accrual rate is approximately 25 patients/month. Current survival rates for the whole study group are: stage I: 95%, stage II: 98%, stage III: 93%, stage IV: 64%. For all patients with stage I disease, the mortality was not cancer related. CONCLUSIONS: Although laparoscopic surgery appears of value in colorectal malignancy, results of randomized trials have to be awaited to determine the definitive place of laparoscopy in colorectal cancer. Considering the current accrual rate, the COLOR study will be completed in 2002. Copyright 2000 S. Karger AG, Basel.
RCT Entities:
BACKGROUND: Laparoscopic surgery has proven to be safe and effective. However, the value of laparoscopic resection for malignancy in terms of cancer outcome can only be assessed by large prospective randomized clinical trials with sufficient follow-up. METHODS: COLOR (COlon carcinoma Laparoscopic or Open Resection) is a European multicenter randomized trial which has started in September 1997. In 24 hospitals in Sweden, The Netherlands, Germany, France, Italy and Spain, 1,200 patients will be included. The primary end point of the study is cancer-free survival after 3 years. RESULTS: Within <2 years, more than 540 patients have been randomized for right hemicolectomy (45%), left hemicolectomy (10%) and sigmoidectomy (45%). 33 patients (6%) were excluded after randomization. The accrual rate is approximately 25 patients/month. Current survival rates for the whole study group are: stage I: 95%, stage II: 98%, stage III: 93%, stage IV: 64%. For all patients with stage I disease, the mortality was not cancer related. CONCLUSIONS: Although laparoscopic surgery appears of value in colorectal malignancy, results of randomized trials have to be awaited to determine the definitive place of laparoscopy in colorectal cancer. Considering the current accrual rate, the COLOR study will be completed in 2002. Copyright 2000 S. Karger AG, Basel.
Authors: Lise Courtot; Bertrand Le Roy; Ricardo Memeo; Thibault Voron; Nicolas de Angelis; Nicolas Tabchouri; Francesco Brunetti; Anne Berger; Didier Mutter; Johan Gagniere; Ephrem Salamé; Denis Pezet; Mehdi Ouaïssi Journal: Int J Colorectal Dis Date: 2018-05-07 Impact factor: 2.571
Authors: Marco Milone; Ugo Elmore; Enrico Di Salvo; Paolo Delrio; Luigi Bucci; Giuseppe Paolo Ferulano; Carmine Napolitano; Maria Rachele Angiolini; Umberto Bracale; Marco Clemente; Michele D'ambra; Gaetano Luglio; Mario Musella; Ugo Pace; Riccardo Rosati; Francesco Milone Journal: Surg Endosc Date: 2014-11-21 Impact factor: 4.584
Authors: Manish Chand; Muhammed R S Siddiqui; Ashish Gupta; Shahnawaz Rasheed; Paris Tekkis; Amjad Parvaiz; Alex H Mirnezami; Tahseen Qureshi Journal: World J Gastroenterol Date: 2014-12-07 Impact factor: 5.742
Authors: Miguel Pera; Heidi Nelson; S Vincent Rajkumar; Tonia M Young-Fadok; Lawrence J Burgart Journal: J Gastrointest Surg Date: 2003 Sep-Oct Impact factor: 3.452